Jyoti Nanda Edinburgh Urological Cancer Group University of Edinburgh Biography Publications Institution JoVE Articles Jyoti Nanda has not added a biography. If you are Jyoti Nanda and would like to personalize this page please email our Author Liaison for assistance. Publications The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma PloS One. 2012 | Pubmed ID: 22363672 Utilizing MRNA Extracted from Small, Archival Formalin-fixed Paraffin-embedded Prostate Samples for Translational Research: Assessment of the Effect of Increasing Sample Age and Storage Temperature International Urology and Nephrology. Dec, 2011 | Pubmed ID: 21448682 DNA Strand Breaks and Hypoxia Response Inhibition Mediate the Radiosensitisation Effect of Nitric Oxide Donors on Prostate Cancer Under Varying Oxygen Conditions Biochemical Pharmacology. Jan, 2011 | Pubmed ID: 20888325 NO-sulindac Inhibits the Hypoxia Response of PC-3 Prostate Cancer Cells Via the Akt Signalling Pathway International Journal of Cancer. Journal International Du Cancer. Jan, 2009 | Pubmed ID: 18924134 Oestrogen and Benign Prostatic Hyperplasia: Effects on Stromal Cell Proliferation and Local Formation from Androgen The Journal of Endocrinology. Jun, 2008 | Pubmed ID: 18492814 استخدام البروتين عكس صالحة المرحلة (RPPA) لاستكشاف البروتين في التعبير التغير فردية سرطان الخلايا الكلوية Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine
استخدام البروتين عكس صالحة المرحلة (RPPA) لاستكشاف البروتين في التعبير التغير فردية سرطان الخلايا الكلوية Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine